**Author details**

Georgy D. Sagaradze1,2, Peter P. Nimiritsky1,2, Zhanna A. Akopyan1,2, Pavel I. Makarevich1,2\* and Anastasia Yu. Efimenko1,2

[10] Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research. 2010;**4**(3):214-222.

"Cell-Free Therapeutics" from Components Secreted by Mesenchymal Stromal Cells as a Novel…

http://dx.doi.org/10.5772/intechopen.78605

59

[11] Bhang SH, Lee S, Shin JY, Lee TJ, Jang HK, Kim BS. Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis.

[12] Liu S, Zhou J, Zhang X, Liu Y, Chen J, Hu B, et al. Strategies to optimize adult stem cell therapy for tissue regeneration. International Journal of Molecular Sciences. 2016;

[13] Nguyen PK, Neofytou E, Rhee J-W, Wu JC. Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease. JAMA

[14] Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. Journal of Translational Medicine. 2011;**9**(1):29. DOI: 10.1186/1479-5876-9-29

[15] Schimke MM, Marozin S, Lepperdinger G. Patient-specific age: The other side of the coin in advanced mesenchymal stem cell therapy. Frontiers in Physiology. 2015;**6**:362. DOI:

[16] Efimenko A, Dzhoyashvili N, Kalinina N, Kochegura T, Akchurin R, Tkachuk V, et al. Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential. Stem Cells Translational Medicine. 2014;**3**(1):32-41.

[17] Efimenko A, Starostina E, Kalinina N, Stolzing A. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. Journal of Translational

[18] Kizilay Mancini O, Shum-Tim D, Stochaj U, Correa JA, Colmegna I. Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression. Stem Cell Research & Therapy. 2015;**6**(1):140. DOI: 10.1186/s13287-015-0127-9 [19] Mohd Ali N, Boo L, Yeap SK, Ky H, Satharasinghe DA, Liew WC, et al. Probable impact of age and hypoxia on proliferation and microRNA expression profile of bone marrowderived human mesenchymal stem cells. PeerJ [Internet]. 2016;**14**(4):e1536. DOI: 10.7717/

[20] Peffers MJ, Collins J, Fang Y, Goljanek-Whysall K, Rushton M, Loughlin J, Proctor C, Clegg PD.Age-related changes in mesenchymal stem cells identified using a multi-omics approach. European Cells & Materials. 2016;**31**:136-159. DOI: 10.22203/eCM.v031a10 [21] Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schäfer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal

stromal cells. BMC Medicine. 2013;**11**(1):146. DOI: 10.1186/1741-7015-11-146

Molecular Therapy. 2014;**22**(4):862-872. DOI: 10.1038/mt.2013.301

Cardiology. 2016;**1**(8):953. DOI: 10.1001/jamacardio.2016.2750

DOI: 10.1016/J.SCR.2009.12.003

**17**(6):982. DOI: 10.3390/ijms17060982

10.3389/fphys.2015.00362

DOI: 10.5966/sctm.2013-0014

peerj.1536

Medicine. 2011;**9**(1):10. DOI: 10.1186/1479-5876-9-10

\*Address all correspondence to: pmakarevich@mc.msu.ru

1 Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov, Moscow State University, Moscow, Russian Federation

2 Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russian Federation
